AbbVie Must Pay $150M For False AndroGel Ads, Jury Says

Law360, Chicago (July 24, 2017, 2:16 PM EDT) -- An Illinois federal jury on Monday found that AbbVie Inc. isn't liable for an AndroGel user's heart attack but ordered the company to pay $150 million in punitive damages for funding ads that misrepresented what the testosterone replacement therapy drug could treat.

Monday's verdict is the first in the multidistrict litigation over testosterone gel products concentrated in Illinois federal court. Shown is a computer display at an unrelated 2007 arbitration hearing in California. (AP) The award is an unusual ending to a three-week trial over claims...
To view the full article, register now.

Related

Sections

Case Information

Case Title

In Re: Testosterone Replacement Therapy Products Liability Litigation


Case Number

1:14-cv-01748

Court

Illinois Northern

Nature of Suit

367(Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability)

Judge

Honorable Matthew F. Kennelly

Date Filed

March 14, 2014


Case Title

Mitchell et al v. AbbVie, Inc. et al


Case Number

1:14-cv-09178

Court

Illinois Northern

Nature of Suit

367(Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability)

Judge

Honorable Matthew F. Kennelly

Date Filed

November 17, 2014

Law Firms

Companies

Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.